The US biosimilar market: Predictions for 2021
pharmaphorum
JANUARY 28, 2021
In 2020, we saw seven of the 20 biosimilars currently available in the US launch. The United States biosimilar market experienced a significant increase in competition in 2020. More than 30 million Americans have diabetes and another 88 million are at risk of developing it. million patients.
Let's personalize your content